Independent HPLC & CoA Verified
COA VerifiedBatch tested for chemical identity, assay purity, sterility, endotoxins and particulate clearance.
Royal Pharma GLOW Peptide Blend (70mg)
Advanced dermal, hair, and tendon cellular regeneration research matrix by Royal Pharma combining Copper Tripeptide-1 (GHK-Cu 50mg), BPC-157 (10mg), and Thymosin Beta-4 (TB-500 10mg) for extracellular matrix remodeling and angiogenic pathway studies.
Technical Specifications
RUO CertifiedAssay Purity
99.2% Purity (HPLC Verified)
Storage Protocol
-20°C sealed desiccated storage
Format / Concentration
70mg / 3mL synergistic lyophilized blend (GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg)
Synthesis Origin
Royal Pharma European Biotech Labs
Access Status
Authorized Researchers Only
Strictly Research Use Only (RUO). Not for diagnostic, veterinary, or human medical procedures. Handled exclusively by authorized laboratory investigators.
Synergistic Tri-Peptide Matrix (GHK-Cu + BPC-157 + TB-500)
The Royal Pharma GLOW Blend combines Copper Tripeptide-1 (GHK-Cu 50mg), Pentadecapeptide BPC-157 (10mg), and Thymosin Beta-4 fragment TB-500 (10mg) in a single 70mg lyophilized research matrix.
Engineered for comparative in-vitro cellular migration, angiogenesis, actin-sequestering, and tendon/dermal extracellular matrix remodeling protocols under controlled laboratory conditions.
Matrix Ratio
50 / 10 / 10 mg
GHK-Cu + BPC-157 + TB-500
Assay Focus
ECM & Angiogenesis
Fibroblast & endothelial models
Purity Standard
99.2% HPLC
Multi-peak chromatographic CoA
Synthesized and verified under strict aseptic analytical controls with full batch-level chain-of-custody documentation and independent chromatographic identity release testing.